MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Josép María
Ribera Santasusana
Publicaciones en las que colabora con Josép María Ribera Santasusana (11)
2011
-
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
Blood, Vol. 117, Núm. 6, pp. 1799-1805
2010
2007
-
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors
Blood, Vol. 110, Núm. 1, pp. 461-467
2005
-
Minimal residual disease monitoring in multiple myeloma: A comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry
Haematologica, Vol. 90, Núm. 10, pp. 1365-1372
2001
-
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the spanish group PETHEMA
Haematologica, Vol. 86, Núm. 8, pp. 807-813
-
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate-risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL
Haematologica, Vol. 86, Núm. 6, pp. 586-595
-
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARα isoforms: A study of the PETHEMA group
British Journal of Haematology, Vol. 114, Núm. 1, pp. 99-103
2000
-
Definition of relapse risk and role of nonanthracycline drags for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups
Blood, Vol. 96, Núm. 4, pp. 1247-1253
-
Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo
Haematologica, Vol. 85, Núm. 5, pp. 481-485
1999
1998
-
Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
Annals of Oncology, Vol. 9, Núm. 8, pp. 849-855